Medistim ASA

OM:MEDIO Stock Report

Market Cap: NOK 3.2b

Medistim Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Kari Krogstad

Chief executive officer

NOK 7.2m

Total compensation

CEO salary percentage42.0%
CEO tenure15yrs
CEO ownership0.4%
Management average tenure9.8yrs
Board average tenure1.7yrs

Recent management updates

No updates

Recent updates

No updates

CEO Compensation Analysis

How has Kari Krogstad's remuneration changed compared to Medistim's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

NOK 104m

Mar 31 2024n/an/a

NOK 103m

Dec 31 2023NOK 7mNOK 3m

NOK 104m

Sep 30 2023n/an/a

NOK 117m

Jun 30 2023n/an/a

NOK 116m

Mar 31 2023n/an/a

NOK 116m

Dec 31 2022NOK 9mNOK 3m

NOK 114m

Sep 30 2022n/an/a

NOK 98m

Jun 30 2022n/an/a

NOK 92m

Mar 31 2022n/an/a

NOK 93m

Dec 31 2021NOK 6mNOK 3m

NOK 91m

Sep 30 2021n/an/a

NOK 88m

Jun 30 2021n/an/a

NOK 84m

Mar 31 2021n/an/a

NOK 70m

Dec 31 2020NOK 6mNOK 3m

NOK 69m

Sep 30 2020n/an/a

NOK 71m

Jun 30 2020n/an/a

NOK 74m

Mar 31 2020n/an/a

NOK 75m

Dec 31 2019NOK 4mNOK 3m

NOK 70m

Sep 30 2019n/an/a

NOK 79m

Jun 30 2019n/an/a

NOK 73m

Mar 31 2019n/an/a

NOK 64m

Dec 31 2018NOK 4mNOK 2m

NOK 57m

Sep 30 2018n/an/a

NOK 46m

Jun 30 2018n/an/a

NOK 48m

Mar 31 2018n/an/a

NOK 45m

Dec 31 2017NOK 4mNOK 2m

NOK 48m

Compensation vs Market: Kari's total compensation ($USD685.94K) is about average for companies of similar size in the Swedish market ($USD599.98K).

Compensation vs Earnings: Kari's compensation has been consistent with company performance over the past year.

CEO

Kari Krogstad (60 yo)

15yrs

Tenure

NOK 7,205,702

Compensation

Ms. Kari Eian Krogstad serves as Independent Director at Vistin Pharma ASA since June 24, a2020. She has been the Chief Executive Officer of Medistim ASA since September 1, 2009 and serves as its President...

Leadership Team

NamePositionTenureCompensationOwnership
Kari Krogstad
CEO & President15yrsNOK 7.21m0.39%
NOK 12.5m
Thomas Jakobsen
Chief Financial Officerno dataNOK 2.77m0.17%
NOK 5.4m
Helge Borslid
Vice President of Operationsno dataNOK 1.67mno data
Hæge Johanne Wetterhus
Vice President of Marketing14.1yrsNOK 1.87m0.0087%
NOK 281.7k
Hakon Grothe
Chief Innovation Officer5.4yrsNOK 1.91m0.043%
NOK 1.4m
Ole Eiksund
Chief Business Development Officer2.4yrsNOK 1.68m0.032%
NOK 1.0m
Mike Farbelow
President of Medistim USA Incno dataNOK 3.63m0.011%
NOK 352.4k
Roger Morberg
Vice President of Sales - APACno dataNOK 2.55m0.089%
NOK 2.9m
Stephanie Stenhagen
Vice President of Sales EMEAno dataNOK 1.79m0.015%
NOK 492.7k
Ole Robsrud
Managing Director of Medistim Norge ASno dataNOK 1.83m0.019%
NOK 609.1k

9.8yrs

Average Tenure

60yo

Average Age

Experienced Management: MEDIO's management team is seasoned and experienced (9.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Oyvin Broymer
Chairman24.7yrsNOK 495.00k7.02%
NOK 227.4m
Anna Ahlberg
Independent Director1.4yrsno datano data
Jon Hoem
Independent Director1.7yrsno datano data
Ole Dahlberg
Independent Director1.4yrsno datano data
Tove Raanes
Independent Director10.7yrsNOK 300.00kno data
Peder Strand
Directorno datano datano data
Gry Dahle
Directorno datano datano data

1.7yrs

Average Tenure

54yo

Average Age

Experienced Board: MEDIO's board of directors are not considered experienced ( 1.7 years average tenure), which suggests a new board.